Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Mounjaro one day early is not recommended as standard practice, but it will not automatically cause harm. The licensed schedule is once every seven days, and shifting your injection by a single day occasionally does not void your treatment — what matters most is keeping a consistent weekly rhythm going forward. These are prescription-only medicines, and any change to your schedule should be discussed with the prescriber who manages your treatment. The NHS tirzepatide guidance and the medicine's own Patient Information Leaflet are the two most specific references available to you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the concern our prescribers hear most often, and it is worth setting straight gently. A weekly injection is not like a daily tablet where missing one day and taking two the next creates a sharp spike. Tirzepatide is designed to maintain stable levels across a seven-day window. Its half-life is roughly five days, which means there is still a meaningful amount of the medicine active in your system on day six. Taking the next pen a day early does not flood your system — it trims one day from the tail end of that steady state.
That does not make early injections a free choice. The prescriber sets your schedule for good reasons, and the licensed interval exists because it was the one tested in clinical trials, including SURMOUNT-1, where thousands of adults followed strict once-weekly dosing throughout. Drifting earlier week after week would progressively shorten each interval, which is a different and more significant matter than a single one-day shift.
The short answer: a single day early, once, is unlikely to be clinically meaningful. Doing it routinely is not the same thing, and you should not do it without speaking to your prescriber first. Let the misconception go, and focus on what actually matters, which is consistency.
The weekly schedule is not arbitrary. Tirzepatide's pharmacokinetics (how the medicine behaves in the body) were built around a seven-day dosing window. Eli Lilly's clinical programme tested this interval across thousands of participants to establish safety, tolerability and the titration steps that start at 2.5mg. The interval also allows any injection-site reactions or gastrointestinal effects to settle before the next dose arrives.
Shortening the gap to six days compresses that window slightly. For most people, this will not produce a noticeable difference in side effects, because the difference in active drug level between day six and day seven is modest. What it can do, if repeated, is create a gradual schedule drift, so that within a few months you have effectively moved your injection day forward by a week without realising. That is the practical risk, not an acute medical one.
If you genuinely need to move your injection day, say because of a holiday or a pattern change, there is a structured way to do it. Your prescriber can tell you whether to take the dose early or wait slightly longer to land on your new preferred day. Never adjust a dose or skip one without clinical guidance, the Patient Information Leaflet inside your pen box covers this, and it is the most precise reference for your specific dose.
The Mounjaro SmPC, published on the Electronic Medicines Compendium (eMC), sets out the licensed dosing frequency clearly: once weekly, on the same day each week, which can be changed if required as long as the minimum gap between doses is kept. That minimum gap detail is the key piece of information, and it is in the leaflet you receive with your prescription, we do not reproduce it here because your prescriber should confirm it in the context of your current dose and treatment plan.
If you are using a private service like Mounjaro through nume, your prescriber is available to answer timing questions before you act. For one-off schedule questions that do not warrant a full review, the FAQs section covers common queries, and our aftercare team is reachable seven days a week via the contact page. The right move is always to ask first, inject second.
For a broader look at how tirzepatide works and what the clinical evidence says about its effects, the tirzepatide overview covers the mechanism and trial results in full. If you are at an earlier stage and weighing up whether treatment is right for you at all, the weight-loss treatment overview is a useful starting point, including a look at what Mounjaro costs privately and what that price should include.
Most timing questions about Mounjaro are not urgent. If you realise on a Sunday that your usual day is Saturday and you forgot, or you want to move your injection to a different day of the week, that is a prescriber conversation rather than an emergency. Call or message them before your next scheduled dose.
There are situations where you should act faster. If you have already taken a dose and are wondering whether you took it too soon because you lost track of the week, check your packaging or app record first. If you are genuinely unsure whether you have already injected, do not take another dose, contact your prescriber the same day. If you experience any unusual or severe symptoms after an early injection, including severe stomach pain that spreads to the back, contact your GP or call 111 promptly. The MHRA advises that pancreatitis, though infrequent, is a known side effect of GLP-1 medicines and warrants urgent assessment when symptoms fit that pattern.
More general timing questions, including what to do if you are significantly earlier or later than planned, are covered in detail on our page on taking Mounjaro early or late. If you are thinking about a shift of more than one day, the two-days-early guide and the three-days-early page address those scenarios specifically.
If you are not yet on treatment and are considering starting, you can start a free consultation with our prescribers. A real clinician reads every submission the same day, no algorithms, no automated approvals.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.